Skip to content
TrustList
Novaquest Capital Management logo
Venture capital firm

Novaquest Capital Management

Late-stage product finance investor in biopharmaceutical products, with animal health partnerships

Novaquest Capital Management cover

TrustList summary

Novaquest Capital Management invests in late-stage biopharmaceutical products through a model it calls product finance. It also forms partnerships with animal health companies. Its financing deals have supported drug developers without issuing new shares in some cases.

What Novaquest Capital Management does

  • Product finance: funding tied to specific biopharma products late in development.
  • Royalty monetisation: for example, a financing with FibroGen.
  • Non-dilutive finance: for example, a deal with Hansa Biopharma supporting its antibody-cleaving enzyme platform.
  • Equity rounds: it took part in a Series C round for TARGAN, a poultry vaccine delivery company.
  • Animal health partnerships: collaboration with companies in that field.

Key facts

  • Focus: biopharmaceutical products
  • Stage: late-stage

Summary written by TrustList from the business's own published information, Oct 2026.

Categories & features

Ask TrustList to introduce you to Novaquest Capital Management

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Novaquest Capital Management

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Novaquest Capital Management.

Novaquest Capital Management alternatives

Similar listings buyers compare against this one.

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Venture capital firm partnering with founders from first idea through to public listing

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications

Venture capital firm with a portfolio spanning tutoring, healthcare, recruiting, trucking safety, policing and sports software

Baltimore foundation that funds research and commissions reports on public issues affecting the city and Maryland

Vienna investment fund providing revenue-based financing to European software and technology growth companies

Venture capital firm backing technology-enabled companies in Latin America that want to scale globally

Pre-seed fund and accelerator backing startups that build resilience for underserved, climate-vulnerable communities